BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu R, Zhang X, Fan Z, Wang Y, Yao G, Wan X, Liu Z, Yang B, Yu L. Human amniotic mesenchymal stem cells improve the follicular microenvironment to recover ovarian function in premature ovarian failure mice. Stem Cell Res Ther. 2019;10:299. [PMID: 31578152 DOI: 10.1186/s13287-019-1315-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Bahrehbar K, Gholami S, Nazari Z, Malakhond MK. Embryonic stem cells-derived mesenchymal stem cells do not differentiate into ovarian cells but improve ovarian function in POF mice. Biochemical and Biophysical Research Communications 2022;635:92-98. [DOI: 10.1016/j.bbrc.2022.10.014] [Reference Citation Analysis]
2 Sun Y, Wang TE, Hu Q, Zhang W, Zeng Y, Lai X, Zhang L, Shi M. Systematic comparation of the biological and transcriptomic landscapes of human amniotic mesenchymal stem cells under serum-containing and serum-free conditions. Stem Cell Res Ther 2022;13:490. [PMID: 36195964 DOI: 10.1186/s13287-022-03179-2] [Reference Citation Analysis]
3 Barad DH, Gleicher N. Optimal IVF Protocols for Women over 40 and Low Functional Ovarian Reserve. Optimizing the Management of Fertility in Women over 40 2022. [DOI: 10.1017/9781009025270.008] [Reference Citation Analysis]
4 Shi L, Zhang Z, Deng M, Zheng F, Liu W, Ye S. Biological mechanisms and applied prospects of mesenchymal stem cells in premature ovarian failure. Medicine (Baltimore) 2022;101:e30013. [PMID: 35960112 DOI: 10.1097/MD.0000000000030013] [Reference Citation Analysis]
5 Zhang L, Sun Y, Zhang XX, Liu YB, Sun HY, Wu CT, Xiao FJ, Wang LS. Comparison of CD146 +/- mesenchymal stem cells in improving premature ovarian failure. Stem Cell Res Ther 2022;13:267. [PMID: 35729643 DOI: 10.1186/s13287-022-02916-x] [Reference Citation Analysis]
6 Zhao Y, Pan S, Wu X. Human umbilical cord mesenchymal stem cell-derived exosomes inhibit ovarian granulosa cells inflammatory response through inhibition of NF-κB signaling in polycystic ovary syndrome. Journal of Reproductive Immunology 2022. [DOI: 10.1016/j.jri.2022.103638] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Guo L, Gao Q, Zhu J, Jin X, Yin H, Liu T. A Docosahexaenoic Acid Derivative (N-Benzyl Docosahexaenamide) as a Potential Therapeutic Candidate for Treatment of Ovarian Injury in the Mouse Model. Molecules 2022;27:2754. [PMID: 35566104 DOI: 10.3390/molecules27092754] [Reference Citation Analysis]
8 Fu X, Zhang S, Li T, Zhang R, Lu Y, Cheng H, Xu Y, Qin H, Liu Y, Lin J. Menstrual blood-derived endometrial stem cells ameliorate the viability of ovarian granulosa cells injured by cisplatin through activating autophagy. Reprod Toxicol 2022:S0890-6238(22)00038-7. [PMID: 35346788 DOI: 10.1016/j.reprotox.2022.03.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Zhang L, Han Z. Mesenchymal Stem/Stromal Cells and Hydrogel Scaffolds for Tissue Engineering. Hydrogels - From Tradition to Innovative Platforms With Multiple Applications [Working Title] 2022. [DOI: 10.5772/intechopen.101793] [Reference Citation Analysis]
10 Ramuta Železnik T, Tratnjek L, Kreft Erdani M. Amniotic Membrane: A Unique Combination of Stem-Like Cells, Extracellular Matrix with Indispensable Potential for Regenerative Medicine. Stem Cell Biology and Regenerative Medicine 2022. [DOI: 10.1007/978-3-030-90111-0_13] [Reference Citation Analysis]
11 Virant-klun I. Regeneration of Human Ovaries Through Mesenchymal Stem Cell Transplantation is Becoming a Reality. Stem Cell Biology and Regenerative Medicine 2022. [DOI: 10.1007/978-3-030-90111-0_2] [Reference Citation Analysis]
12 Wu JX, Xia T, She LP, Lin S, Luo XM. Stem Cell Therapies for Human Infertility: Advantages and Challenges. Cell Transplant 2022;31:9636897221083252. [PMID: 35348026 DOI: 10.1177/09636897221083252] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang J, Liu W, Yu D, Yang Z, Li S, Sun X. Research Progress on the Treatment of Premature Ovarian Failure Using Mesenchymal Stem Cells: A Literature Review. Front Cell Dev Biol 2021;9:749822. [PMID: 34966738 DOI: 10.3389/fcell.2021.749822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Yin J, Chang H, Li R, Leung PC. Recent progress in the treatment of women with diminished ovarian reserve. Gynecology and Obstetrics Clinical Medicine 2021;1:186-9. [DOI: 10.1016/j.gocm.2021.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Pan XH, Zhang XJ, Yao X, Tian NN, Yang ZL, Wang K, Zhu XQ, Zhao J, He J, Cai XM, Pang RQ, Ruan GP. Effects and mechanisms of mUCMSCs on ovarian structure and function in naturally ageing C57 mice. J Ovarian Res 2021;14:133. [PMID: 34645513 DOI: 10.1186/s13048-021-00854-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Li Z, Zhang M, Tian Y, Li Q, Huang X. Mesenchymal Stem Cells in Premature Ovarian Insufficiency: Mechanisms and Prospects. Front Cell Dev Biol 2021;9:718192. [PMID: 34414193 DOI: 10.3389/fcell.2021.718192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
17 Zhou Y, Zhou J, Xu X, Du F, Nie M, Hu L, Ma Y, Liu M, Yu S, Zhang J, Chen Y. Matrigel/Umbilical Cord-Derived Mesenchymal Stem Cells Promote Granulosa Cell Proliferation and Ovarian Vascularization in a Mouse Model of Premature Ovarian Failure. Stem Cells Dev 2021;30:782-96. [PMID: 34030464 DOI: 10.1089/scd.2021.0005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
18 Kinnear HM, Tomaszewski CE, Chang FL, Moravek MB, Xu M, Padmanabhan V, Shikanov A. The ovarian stroma as a new frontier. Reproduction 2020;160:R25-39. [PMID: 32716007 DOI: 10.1530/REP-19-0501] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 34.0] [Reference Citation Analysis]
19 Liu H, Jiang C, La B, Cao M, Ning S, Zhou J, Yan Z, Li C, Cui Y, Ma X, Wang M, Chen L, Yu Y, Chen F, Zhang Y, Wu H, Liu J, Qin L. Human amnion-derived mesenchymal stem cells improved the reproductive function of age-related diminished ovarian reserve in mice through Ampk/FoxO3a signaling pathway. Stem Cell Res Ther 2021;12:317. [PMID: 34078462 DOI: 10.1186/s13287-021-02382-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Ulin M, Cetin E, Hobeika E, Chugh RM, Park HS, Esfandyari S, Al-Hendy A. Human Mesenchymal Stem Cell Therapy and Other Novel Treatment Approaches for Premature Ovarian Insufficiency. Reprod Sci 2021;28:1688-96. [PMID: 33956339 DOI: 10.1007/s43032-021-00528-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
21 Petric P, Vrtacnik-Bokal E, Stimpfel M. Is It Possible to Treat Infertility with Stem Cells? Reprod Sci 2021;28:1733-45. [PMID: 33834375 DOI: 10.1007/s43032-021-00566-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhang L, Xiong N, Liu Y, Gan L. Biomimetic cell-adhesive ligand-functionalized peptide composite hydrogels maintain stemness of human amniotic mesenchymal stem cells. Regen Biomater 2021;8:rbaa057. [PMID: 33738111 DOI: 10.1093/rb/rbaa057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Zhang S, Huang B, Su P, Chang Q, Li P, Song A, Zhao X, Yuan Z, Tan J. Concentrated exosomes from menstrual blood-derived stromal cells improves ovarian activity in a rat model of premature ovarian insufficiency. Stem Cell Res Ther 2021;12:178. [PMID: 33712079 DOI: 10.1186/s13287-021-02255-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
24 Wang MY, Wang YX, Li-Ling J, Xie HQ. Adult Stem Cell Therapy for Premature Ovarian Failure: From Bench to Bedside. Tissue Eng Part B Rev 2021. [PMID: 33427039 DOI: 10.1089/ten.TEB.2020.0205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
25 Fu YX, Ji J, Shan F, Li J, Hu R. Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities. Stem Cell Res Ther 2021;12:161. [PMID: 33658073 DOI: 10.1186/s13287-021-02212-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
26 Fouad H, Faruk EM, Alasmari WA, Nadwa EH, Ebrahim UFA. Structural and chemical role of mesenchymal stem cells and resveratrol in regulation of apoptotic -induced genes in Bisphenol-A induced uterine damage in adult female albino rats. Tissue Cell 2021;70:101502. [PMID: 33582552 DOI: 10.1016/j.tice.2021.101502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Zhang Y, Zhou X, Zhu Y, Wang H, Xu J, Su Y. Current mechanisms of primordial follicle activation and new strategies for fertility preservation. Mol Hum Reprod 2021;27:gaab005. [PMID: 33538812 DOI: 10.1093/molehr/gaab005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Wu S, Wang Y, Ding H, Sun N, Liu Y, Wang L, Sheng F, Zhang H, Yang F, Li W. The Efficacy and Safety of the mTOR Signaling Pathway Activator, MHY1485, for in vitro Activation of Human Ovarian Tissue. Front Genet 2020;11:603683. [PMID: 33613618 DOI: 10.3389/fgene.2020.603683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Liu QW, Huang QM, Wu HY, Zuo GS, Gu HC, Deng KY, Xin HB. Characteristics and Therapeutic Potential of Human Amnion-Derived Stem Cells. Int J Mol Sci 2021;22:970. [PMID: 33478081 DOI: 10.3390/ijms22020970] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 21.0] [Reference Citation Analysis]
30 Adamyan L, Sibirskaya E, Shcherina A. Pathogenetic aspects of premature ovarian failure. Probl reprod 2021;27:6. [DOI: 10.17116/repro2021270116] [Reference Citation Analysis]
31 Bahrehbar K, Rezazadeh Valojerdi M, Esfandiari F, Fathi R, Hassani SN, Baharvand H. Human embryonic stem cell-derived mesenchymal stem cells improved premature ovarian failure. World J Stem Cells 2020; 12(8): 857-878 [PMID: 32952863 DOI: 10.4252/wjsc.v12.i8.857] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
32 Huang B, Ding C, Zou Q, Lu J, Wang W, Li H. Human Amniotic Fluid Mesenchymal Stem Cells Improve Ovarian Function During Physiological Aging by Resisting DNA Damage. Front Pharmacol 2020;11:272. [PMID: 32273842 DOI: 10.3389/fphar.2020.00272] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
33 Zafardoust S, Kazemnejad S, Darzi M, Fathi-kazerooni M, Rastegari H, Mohammadzadeh A. Improvement of Pregnancy Rate and Live Birth Rate in Poor Ovarian Responders by Intraovarian Administration of Autologous Menstrual Blood Derived- Mesenchymal Stromal Cells: Phase I/II Clinical Trial. Stem Cell Rev and Rep 2020;16:755-63. [DOI: 10.1007/s12015-020-09969-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
34 Bharti D, Jang SJ, Lee SY, Lee SL, Rho GJ. In Vitro Generation of Oocyte Like Cells and Their In Vivo Efficacy: How Far We have been Succeeded. Cells 2020;9:E557. [PMID: 32120836 DOI: 10.3390/cells9030557] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
35 Zhou T, Liao C, Li HY, Lin W, Lin S, Zhong H. Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis. Stem Cell Res Ther 2020;11:48. [PMID: 32019582 DOI: 10.1186/s13287-019-1538-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]